Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene

Journal of Immunology

Volumn 160, Issue 6, 1998, Pages 2940-2946

  Fenyk Melody, Judy E ^a,c   Garrison, Augusta E ^a   Brunnert, Steven R ^b   Weidner, Jeffrey R ^a   Shen, Frank ^a   Shelton, Beverly A ^a   Mudgett, John S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Inst Compar Med Postdoctoral M ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; DISEASE SEVERITY; HISTOPATHOLOGY; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCORING SYSTEM;

AMINO ACID SEQUENCE; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GUANIDINES; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 0032520762     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Bo, L., T. M. Dawson, S. Wesselingh, S. Mork, S. Choi, P. A. Kong, D. Hanley, and B. D. Trapp. 1994. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:778.
2. Cross, A., R. Lin, and T. Lin. 1993. Localization of nitric oxide (NO) in spinal cords of mice with experimental autoimmune encephalomyelitis (EAE). J. Immunol. 150:246A.
3. Moilanen, E., and H. Vapaatala. 1995. Nitric Oxide in inflammation and immune response. Ann. Med. 27:359.
4. Kolb, H., and V. Kolb-Bachofen. 1992. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol. Today 13:157.
5. Pfeilschifter, J., W. Eberhardt, R. Hummel, D. Kunz, H. Muhl, D. Nitsch, C. Pluss, and G. Walker. 1996. Therapeutic strategies for the inhibition of inducible nitric oxide synthase: potential for a novel class of anti-inflammatory agents. Cell Biol. Int. 20:51.
6. Brosnan, C. F., L. Battistini, C. S. Raine, D. W. Dickson, A. Casadevall, and S. C. Lee. 1994. Reactive nitrogen intermediates in human neuropathology: an overview. Dev. Neurosci. 16:152.
7. Campbell, I. L., A. Samimi, and C.-S. Chiang. 1994. Expression of the inducible nitric oxide synthase: correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. J. Immunol. 153:3622.
8. Liew, F. Y. 1995. Nitric oxide in infectious and autoimmune diseases. Ciba Found. Symp. 195:234.
9. Buster, B. L., A. C. Weintrob, G. C. Townsend, and W. M. Scheid. 1995. Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect. Immun. 63:3835.
10. Marietta, M. A. 1994. Nitric oxide synthase: aspects concerning structure and catalysts. Cell 78:927.
11. Schulz, J. B., R. T. Matthews, and M. F. Beal. 1995. Role of nitric oxide in neurodegenerative diseases. Curr. Opin. Neurol. 8:480.
12. Billiar, T. R. 1995. Nitric oxide: novel biology with clinical relevance. Ann. Surg. 221:339.
13. Lin, R. F., T.-S. Lin, R. G. Tilton, and A. H. Cross. 1993. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178:643.
14. Schmidt, H. H. H. W., and U. Walter. 1994. NO at work. Cell 78:919.
15. Leib, S. L., Y. S. Kim, S. M. Black, and M. G. Tauber. 1996. Inducible nitric oxide synthase (iNOS) is upregulated in experimental meningitis, but NOS inhibition is detrimental. J. Invest. Med. 44:PA111.
16. Onufriev, M. V., and N. V. Gulyaeva. 1995. Recording of NADPH oxidation as a means of estimating NO synthase activity. Bull. Exp. Biol. Med. 120:792.
17. Tay, S. S. W. 1995. Localization of NADPH-diaphorase (nitric oxide synthase)-positive neurons in the monkey spinal cord. FASEB 9:PA248.
18. Scott, G. S., P. Lees, K. I. Williams, and C. Bolton. 1994. The role of nitric oxide (NO) in neurovascular disruption during the development of experimental allergic encephalomyelitis (EAE) in Lewis rats. J. Physiol. 0:480.
19. Damiani, P., and G. Burini. 1986. Fluorometric determination of nitrite. Talanta 33:649.
20. Misko, T. P., R. J. Schilling, D. Salvemini, W. M. Moore, and M. G. Currie. 1993. A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214:11.
21. MacMicking, J. D., D. O. Willenborg, M. J. Weidemann, K. A. Rockett, and W. B. Cowden. 1992. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176:303.
22. Feinstein, D. L., and B. R. Apatoff. 1995. Inducible nitric oxide synthase expression in multiple sclerosis brain. Neurology 45:A467.
23. Bagasra, O., F. H. Michaels, Y. M. Zheng, L. E. Bobroski, S. V. Spitsin, Z. F. Fu, R. Tawadros, and H. Koprowski. 1995. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 92:12041.
24. Okuda, Y., Y. Nakatsuji, H. Fujimura, H. Esumi, T. Ogura, T. Yanagihara, and S. Sakoda. 1995. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalitis. J. Neuroimmunol. 62:103.
25. Mollace, V., and G. Nistico. 1995. Release of nitric oxide from astroglial cells: a key mechanism in neuroimmune disorders. Adv. Neuroimmunol. 5:421.
26. Seo, H. G., N. Fujiwara, H. Kaneto, M. Asahi, J. Fujii, and N. Taniguchi. 1996. Effect of a nitric oxide synthase inhibitor, S-ethylisothiourea, on cultured cells and cardiovascular function of normal and lipopolysaccharide-treated rabbits. J. Biochem. 119:553.
27. Ovadia, H., D. Lehmann, R. Kol-Mizrachi, and O. Abrahamsky. 1994. Inhibition of experimental allergic encephalomyelitis by nitric oxide synthase inhibitor. J. Neuroimmunol. 54:188.
28. Ruuls, S. R., S. V. D. Linden, K. Sontrop, I. Huitinga, and C. D. Dijkstra. 1996. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:467.
29. Wu, C.-C., S.-J. Chen, C. Szabo, C. Thiemermann, and J. R. Vane. 1995. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol. 114:1666.
30. Cross, A. H., T. P. Misko, R. F. Lin, W. F. Hickey, J. L. Trotter, and R. G. Tilton. 1994. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:2684.
31. Zielasek, J., S. Jung, B. Schmidt, F. Y. Liew, Q. W. Xie, H. Cho, C. S. Nathan, K. V. Toyka, and H. P. Hartung. 1992. Role of NO synthase in experimental autoimmune neuritis (EAN) and experimental autoimmune encephalitis (EAE). Immunobiology 186:34.
32. Lopez-Belmonte, J., B. J. R. Whittle, and S. Moncada. 1995. Aminoguanidine promotes vasoconstriction and leukocyte adherence in rat mesentery through inhibition of constitutive nitric-oxide synthase. Gastroenterology 108:302.
33. Scott, G. S., K. I. Williams, and C. Bolton. 1995. The effects of nitric oxide inhibition on experimental allergic encephalomyelitis in the Lewis rat. Br. J. Pharmacol. 115:98.
34. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q.-W. Xie, K. Sokol, N. Hutchinson, H. Chen, and J. S. Mudgett. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641.
35. Wei, X.-Q., I. G. Charles, A. Smith, J. Ure, G.-J. Feng, F.-P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking nitric oxide synthase. Nature 375:408.
36. Raine, C. S. 1994. The Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. Ann. Neurol. 36:S61.
37. Swanborg, R. H. 1995. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin. Immunol. Immunopathol. 77:4.
38. Cross, A. H., V. K. Tuohy, and C. S. Raine. 1993. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell. Immunol. 146:261.
39. Bigazzi, P. E. 1995. Animal models of multiple sclerosis. Clin. Immunol. Immunopathol. 77:3.
40. Canto, M. C. D., R. W. Melvold, B. S. Kim, and S. D. Miller. 1995. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection: a pathological and immunological comparison. Microsc. Res. Tech. 32:215.
41. Wekerle, H., K. Kojima, J. Lanes-viera, H. Lassmann, and C. Linington. 1994. Animal models. Ann. Neurol. 36:S47.
42. Levine, S., and R. Sowinski. 1984. Treatment of experimental allergic encephalomyelitis with myelin basic protein: which route is best? Neurochem. Res. 9:1417.
43. Alvord, E. C., L. M. Rose, and T. L. Richards. 1992. Chronic experimental allergic encephalomyelitis as a model of multiple sclerosis. In Myelin: Biology and Chemistry, Vol. 9. R. E. Martenson, ed. CRC Press, Inc., Boca Raton, FL, p. 849.
44. Hughes, S. 1995. The battle for the multiple sclerosis market. Scrip Word Pharmaceutical News 2064:26.
45. Sun, J., H. Link, T. Olsson, B.-G. Xiao, G. Andersson, H.-P. Erre, C. Lininton, and P. Diener. 1991. T and B cell responses to myelin oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146:1490.
46. Kuchroo, V. K., R. A. Sobel, T. Yamamura, E. Greenfield, M. E. Dorf, and M. B. Lees. 1991. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein specific T cell clones and synthetic peptides. Pathobialogy 59:306.
47. Ben-Nun, A., I. Mendel, R. Bakimer, M. Fridkis-Hareli, D. Teitelbaum, R. Arnon, M. Sela, and N. Kerlero de Rosbo. 1996. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease. J. Neurol. 243:S14.
48. Kerlero de Rosbo, N., I. Mendel, and A. Ben-Nun. 1995. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur. J. Immunol. 25:985.
49. + T cells. Eur. J. Immunol. 24:2250.
50. Levine, S., A. Saltzman, and G. E. Deibler. 1990. Encephalitogenicity for rats of myelin basic protein without the aid of water-in-oil emulsions. J. Neuropathol. Exp. Neurol. 49:480.
51. Sobel, R. A., and V. K. Kuchroo. 1992. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. J. Immunol. 149:1444.
52. Tsunoda, I., and R. S. Fujinami. 1996. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J. Neuropathol. Exp. Neurol. 55:673.
53. Cross, A. H., B. Cannella, C. F. Brosnan, and C. S. Raine. 1990. Homing to central nervous system vasculature by antigen-specific lymphocytes. Lab. Invest. 63:162.
54. Fallis, R. J., C. S. Raine, and D. E. McFarlin. 1989. Chronic relapsing experimental allergic encephalomyelitis in SJL mice following the adoptive transfer of an epitope-specific T cell line. J. Neuroimmunol. 22:93.
55. Kalman, B., H. Alder, and F. D. Lublin. 1995. Characteristics of the T lymphocytes involved in experimental allergic encephalomyelitis. J. Neuroimmunol. 61:107.
56. Goverman, J., A. Woods, L. Larson, L. P. Weiner, L. Hood, and D. M. Zaller. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551.
57. Shaw, M. K., C. Kim, K.-L. Ho, R. P. Lisak, and H. Y. Tse. 1992. A combination of adoptive transfer and antigenic challenge induces consistent murine experimental autoimmune encephalomyelitis in C57BL/6 mice and other reputed resistant strains. J. Neuroimmunol. 39:139.
58. Wekerle, H. 1993. Experimental autoimmune encephalomyelitis as a model for immune mediated CNS disease. Curr. Opin. Neurobiol. 3:779.
59. Zhao, W., R. G. Tilton, J. A. Corbett, M. L. McDaniel, T. P. Misko, J. R. Williamson, A. H. Cross, and W. F. Hickey. 1996. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:123.
60. Zielasek, J., S. Jung, R. Gold, F. Y. Liew, K. V. Toyka, and H. P. Hartung. 1995. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:81.
61. Ruuls, S. R., S. Van Der Linden, K. Sontrop, I. Huitinga, and D. Dijkstra. 1996. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:467.
62. Brenner, T., S. Brocke, F. Szafer, R. A. Sobel, J. F. Parkinson, D. H. Perez, and L. Steinman. 1997. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158:2940.
63. Hooper, D. Craig, O. Bagasra, J. C. Marini, A. Zborek, S. T. Ohnishi, R. Kean, J. M. Champion, A. B. Sarker, L. Bobroski, J. L. Farber, T. Akaike, H. Maeda, and H. Koprowski. 1997. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA 94:2528.
64. National Research Council. 1996. Guide for the Use and Care of Laboratory Animals. ILAR, National Academy Press, Washington, DC.